Works matching AU Kohn, Elise

Results: 107
    1
    2
    3

    A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay.

    Published in:
    Journal of Translational Medicine, 2004, v. 2, p. 4, doi. 10.1186/1479-5876-2-4
    By:
    • Miller, Walter J.;
    • Kayton, Mark L.;
    • Patton, Angela;
    • O'Connor, Sarah;
    • Mei He;
    • Huan Vu;
    • Baibakov, Galina;
    • Lorang, Dominique;
    • Knezevic, Vladimir;
    • Kohn, Elise;
    • Alexander, H. Richard;
    • Stirling, David;
    • Payvandi, Faribourz;
    • Muller, George W.;
    • Libutti, Steven K.
    Publication type:
    Article
    4
    5
    6

    Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 95, doi. 10.1186/1756-9966-29-95
    By:
    • Jain, Lokesh;
    • Sissung, Tristan M.;
    • Danesi, Romano;
    • Kohn, Elise C.;
    • Dahut, William L.;
    • Kummar, Shivaani;
    • Venzon, David;
    • Liewehr, David;
    • English, Bevin C.;
    • Baum, Caitlin E.;
    • Yarchoan, Robert;
    • Giaccone, Giuseppe;
    • Venitz, Jürgen;
    • Price, Douglas K.;
    • Figg, William D.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    The new millennium.

    Published in:
    Cancer (0008543X), 2000, v. 88, n. 1, p. 2, doi. 10.1002/(SICI)1097-0142(20000101)88:1<2::AID-CNCR2>3.0.CO;2-K
    By:
    • Brown, Monica R.;
    • Kohn, Elise C.;
    • Hutter, Robert V. P.
    Publication type:
    Article
    18
    19

    Angiogenesis in ovarian carcinoma.

    Published in:
    Cancer (0008543X), 1997, v. 80, n. 12, p. 2219, doi. 10.1002/(SICI)1097-0142(19971215)80:12<2219::AID-CNCR1>3.0.CO;2-P
    By:
    • Kohn, Elise C.
    Publication type:
    Article
    20
    21

    Cancer's deadly signature.

    Published in:
    Nature Genetics, 2003, v. 33, n. 1, p. 10, doi. 10.1038/ng0103-10
    By:
    • Liotta, Lance A.;
    • Kohn, Elise C.
    Publication type:
    Article
    22
    23

    Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089
    By:
    • Jung-Min Lee;
    • Hays, John L.;
    • Annunziata, Christina M.;
    • Noonan, Anne M.;
    • Minasian, Lori;
    • Zujewski, Jo Anne;
    • Minshu Yu;
    • Gordon, Nicolas;
    • Jiuping Ji;
    • Sissung, Tristan M.;
    • Figg, William D.;
    • Azad, Nilofer;
    • Wood, Bradford J.;
    • Doroshow, James;
    • Kohn, Elise C.
    Publication type:
    Article
    24

    Better Therapeutic Trials in Ovarian Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 4, p. 1, doi. 10.1093/jnci/dju029
    By:
    • Bookman, Michael A.;
    • Gilks, C. Blake;
    • Kohn, Elise C.;
    • Kaplan, Karen O.;
    • Huntsman, David;
    • Aghajanian, Carol;
    • Birrer, Michael J.;
    • Ledermann, Jonathan A.;
    • Oza, Amit M.;
    • Swenerton, Kenneth D.
    Publication type:
    Article
    25
    26

    Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8<sup>+</sup> T cells compared with women with BRCA wild-type disease during the early disease course.

    Published in:
    Oncology Letters, 2019, v. 18, n. 4, p. 3914, doi. 10.3892/ol.2019.10731
    By:
    • Lee, Jung-Min;
    • Botesteanu, Dana-Adriana;
    • Tomita, Yusuke;
    • Yuno, Akira;
    • Lee, Min-Jung;
    • Kohn, Elise C.;
    • Annunziata, Christina M.;
    • Matulonis, Ursula;
    • MacDonald, Lauren A.;
    • Nair, Jayakumar R.;
    • Macneill, Kimberley M.;
    • Trepel, Jane B.
    Publication type:
    Article
    27

    Clinical Proteomics.

    Published in:
    JAMA: Journal of the American Medical Association, 2001, v. 286, n. 18, p. 2211, doi. 10.1001/jama.286.18.2211
    By:
    • Liotta, Lance A.;
    • Kohn, Elise C.;
    • Petricoin, Emanual F.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

    Published in:
    2016
    By:
    • Noonan, Anne M.;
    • Bunch, Kristen P.;
    • Chen, Jin‐Qiu;
    • Herrmann, Michelle A.;
    • Lee, Jung‐Min;
    • Kohn, Elise C.;
    • O'Sullivan, Ciara C.;
    • Jordan, Elizabeth;
    • Houston, Nicole;
    • Takebe, Naoko;
    • Kinders, Robert J.;
    • Cao, Liang;
    • Peer, Cody J.;
    • Figg, W. Douglas;
    • Annunziata, Christina M.;
    • Chen, Jin-Qiu;
    • Lee, Jung-Min
    Publication type:
    journal article
    34
    35
    36
    37
    38
    39
    40

    Ovarian cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 3, p. 474, doi. 10.1002/cncr.27833
    By:
    • Kohn, Elise C.;
    • Hurteau, Jean
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Serum proteomic patterns for detection of prostate cancer.

    Published in:
    2002
    By:
    • Petricoin III, Emanuel F.;
    • Ornstein, David K.;
    • Paweletz, Cloud P.;
    • Ardekani, Ali;
    • Hackett, Paul S.;
    • Hitt, Ben A.;
    • Velasssco, Alfredo;
    • Trucco, Christian;
    • Wiegand, Laura;
    • Wood, Kamillah;
    • Simone, Charles B.;
    • Levine, Peter J.;
    • Linehan, W. Marston;
    • Steinberg, Seth M.;
    • Kohn, Elise C.;
    • Liotta, Lande A;
    • Petricoin, Emanuel F 3rd;
    • Velassco, Alfredo;
    • Emmert-Buck, Michael R;
    • Liotta, Lance A
    Publication type:
    journal article
    47
    48
    49
    50